Appearance of de novo dysplastic spitzoid compound naevus in an adalimumab-treated psoriatic patient: case report and review of the possible causal relationship with TNF-α blockers.
Clínica Universitária de Dermatologia, Faculdade de Medicina da Universidade de Lisboa; Dermatology Research Unit, Institute of Molecular Medicine, Lisboa, Portugal.
Marisa
M
Sousa
João Pedro
JP
Freitas
Joana
J
Antunes
Luís
L
Soares-de-Almeida
Paulo Leal
PL
Filipe
D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D005260:Female; D006801:Humans; D018332:Nevus, Epithelioid and Spindle Cell / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy; D012878:Skin Neoplasms / Q000139:chemically induced*; D013848:Thigh; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab